The Clinical Oncology Next-generation Sequencing Market is anticipated to reach US$ 449.4 Mn in value by 2022. The total market is anticipated to grow at a remarkable CAGR of 16.3% between 2022 and 2029, reaching a valuation of US$ 1.14 Bn by 2029, due to the increasing implementation of next generation sequencing (NGS) in clinical …
Category Archives: Healthcare Trends
Antidiabetics Market in the United States is anticipated to garner US$ 79.6 Billion by 2032 | FMI Study
The global Antidiabetics Market is expected to reach US$ 89.2 billion in 2022, up from US$ 80.4 billion in 2021, with a Y-o-Y growth rate of 10.9%. The industry is expected to reach US$ 223 billion by 2032, with a CAGR of 9.6% between 2022 and 2032. The rising global prevalence of diabetes is expected …
Preclinical Medical Device Testing Services Market is expected to reach a valuation of US$ 6.3 Billion by 2032 | FMI
The global Preclinical Medical Device Testing Services Market was worth US$ 2.8 billion in 2022 and is expected to be worth US$ 6.63 billion by 2032, growing at a CAGR of 9% during the forecast period. Preclinical medical device testing services market growth can be attributed to increasing product complexity and stringent government regulations. The …
Cirrhosis Management Market is expected to grow at a 3.8% CAGR between 2022 and 2032 | FMI
The global Cirrhosis Management Market, which was worth US$ 701.8 million in 2022, is expected to grow at a CAGR of 3.8% between 2022 and 2032, reaching US$ 1,059 million. From 2016 to 21, the market grew at a compounded annual rate of 3.5%. The market’s expansion can be attributed to the rising incidences of …
Clinical Decision Support Systems Market is predicted to advance at a CAGR of 10.4% from 2023 to 2033 | FMI
It is predicted that during the forecast period, the global market for Clinical Decision Support Systems will grow at a moderate rate of 10.4%. Clinical decision support systems will be worth US$ 5.46 billion in 2023, according to the market valuation at the moment. By the year 2033, it is predicted that the market for …
Throat Sprays Market is expected to reach US$ 586.1 Million at a CAGR of 2.1% by 2032 | FMI Study
The global Throat Sprays Market is expected to be worth US$ 473.8 million by the end of 2022. Over the forecast period, sales are expected to increase at a CAGR of 2.1%, reaching US$ 586.1 Million by 2032. According to the report, pumps and dispensers will account for approximately 66.3% of the market in 2021. …
Preventive Medicine Market is set to exceed US$ 623.6 Billion by 2032 | Says FMI Analyst
According to FMI Analysts, the global Preventive Medicine Market is expected to be worth US$ 372 billion in 2022 and to grow at a CAGR of 4.8% from 2022 to 2032. By 2032, the global preventive medicine market is expected to be worth US$ 623.6 billion. Preventive Medicine is a type of medical practice based on the …
Pelvic Reconstruction Market is expected to reach US$ 366.9 Million by 2032 | FMI
The global Pelvic Reconstruction Market is expected to be worth US$ 277.8 million by the end of 2022, and to grow at a CAGR of 2.8% to be worth US$ 366.9 million by 2032. In terms of product type, vaginal slings systems were the market leader in 2021, accounting for approximately 54.2% of the market. …
Continue reading “Pelvic Reconstruction Market is expected to reach US$ 366.9 Million by 2032 | FMI”
Medical Bionic Implant and Artificial Organs Market is expected to reach US$ 66,175.8 million by 2032
The global medical bionic implant and artificial organs market is expected to be worth US$ 27,953.3 million in 2022, with a CAGR of 9.3% to be worth US$ 66,175.8 million from 2022 to 2032. Growing economies, rising healthcare spending, and the introduction of new healthcare facilities are ascribed to growth. The medical bionic implant and …
Extended Release Drugs Market is expected to rise at a CAGR of 11% by 2032
Future Market Insights (FMI) adopted a multidisciplinary approach during the pandemic-era to focus on the growth and development of the Extended Release Drugs Market. The study features insights on the current growth dynamics and the major revenue reforms prevailing in the market as of 2020 along with the key takeaways over the forecast period. Get a …
Continue reading “Extended Release Drugs Market is expected to rise at a CAGR of 11% by 2032”